| Q52933837 | A case-control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture, Japan. |
| Q38491389 | A case-control study of lung cancer screening in Okayama Prefecture, Japan |
| Q34129680 | A population-based cohort study of chest x-ray screening in smokers: lung cancer detection findings and follow-up. |
| Q33781112 | An up to date look at lung cancer screening |
| Q38132079 | Chest X-ray screening for lung cancer: overdiagnosis, endpoints, and randomized population trials |
| Q64258752 | Clarification of the resection line non-intubated segmentectomy using indocyanine green |
| Q48919641 | Early diagnosis of lung cancer: the great challenge. Epidemiological variables, clinical variables, staging and treatment |
| Q50682780 | Economic decision analysis model of screening for lung cancer. |
| Q33837492 | Exploring the uncertainties of early detection results: model-based interpretation of mayo lung project. |
| Q34419269 | Fluorescence bronchoscopy for early detection of lung cancer: a clinical perspective |
| Q30721136 | Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study |
| Q52075219 | Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. |
| Q37615139 | Lung cancer screening and its efficacy |
| Q40613862 | Lung cancer screening with low-dose CT. |
| Q51023411 | Lung metastases detection in CT images using 3D template matching. |
| Q53665107 | Lung nodule detection on thoracic computed tomography images: preliminary evaluation of a computer-aided diagnosis system. |
| Q33583714 | Management of lung cancer |
| Q34963422 | Molecular detection approaches for smoking associated tumors. |
| Q52924849 | Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening. |
| Q30650755 | Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer: which to choose? |
| Q50675686 | Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. |
| Q52930505 | Presenting manifestations, cigarette smoking, and detection bias in age at diagnosis of lung cancer. |
| Q41519933 | Prognostic markers in resectable non-small cell lung cancer |
| Q52898226 | Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. |
| Q33722916 | Screening for cancer in the patient with rheumatic disease |
| Q24247464 | Screening for lung cancer |
| Q33943862 | Small solitary pulmonary nodules |
| Q44233610 | The 'reservoir' of undetected bronchial carcinomas in the general population |
| Q50721540 | The efficacy of lung cancer screening conducted in 1990s: four case-control studies in Japan. |
| Q33714878 | The potential of molecular screening. |
| Q34461768 | The role of photodynamic therapy in the management of stage I/II NSCLC. |
| Q74042124 | [COPD and lung cancer: practical implications] |